Recent 8-K filings for MANE

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 12:32 UTC earnings item 2.02item 9.01

  Veradermics Q1 net loss $27.2M, positive Phase 2/3 results for VDPHL01 hair loss drug

source · MANE on sec.gov